Skip to main content

Vascular and Cardiac Effects of Endothelin

  • Chapter
Endothelin and Its Inhibitors

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 152))

Abstract

Endothelin (ET)-1, the most potent mammalian vasoconstrictor identified to date, was originally characterized as a peptide capable of producing contractile responses that were both sustained and extremely resistant to wash-out (Yanagisawa et al. 1988). Subsequently, ET-1 has been shown to contract both resistance arterioles and venous tissue in addition to conduit arteries (venous tissue generally being more sensitive than arterial vessels; Brain et al. 1988, 1989; Borges et al. 1989b; Cocks et al. 1989; D’Orleans-Juste et al. 1989). Furthermore, since subthreshold concentrations of ET-1 augment the contractile actions of norepinephrine, 5-HT, and angiotensin II, it has been proposed that ET-1 also sensitizes vessels to the actions of other “classical” circulating neurohumoral factors (MacLean and McGrath 1990; Lerman et al. 1991; Nakayama et al. 1991).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achmad TH, Winterscheidt A, Lindemann C, Rao GS (1997) Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration. Meth Find Expl Clin Pharmacol 19:153–159

    CAS  Google Scholar 

  • Adachi H, Shoji T, Goto K (1991) Comparison of the effects of endothelin and BAY k 8644 on cardiohemodynamics in anesthetized pigs. Eur J Pharmacol 193:57–65

    Article  PubMed  CAS  Google Scholar 

  • Ahlborg G, Ottosson-Seeberger A, Hemsen A, Lundberg JM (1996) Central and regional hemodynamic effects during infusion of big endothelin-1 in healthy humans. J Appl Physiol 80:1921–1927

    PubMed  CAS  Google Scholar 

  • Ais G, Novo C, López-Farré A, Romeo JM, López-Novoa JM (1989) Effect of endothelin on systemic and regional hemodynamics in rats. Eur J Pharmacol 170:113–116

    Article  PubMed  CAS  Google Scholar 

  • Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA (1994) Constitutive endothelin-1 over expression promotes smooth muscle proliferation via an external autocrine loop. J Biol Chem 269:10112–10118

    PubMed  CAS  Google Scholar 

  • Armstead WM, Mirro R, Leffler CW, Busija DW (1989) Influence of endothelin on piglet cerebral microcirculation. Am J Physiol 257:H707-H710

    PubMed  CAS  Google Scholar 

  • Asano T, Ikegaki I, Suzuki Y, Satoh SI, Shibuya M (1989) Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345–1351

    Article  PubMed  CAS  Google Scholar 

  • Asano T, Ikegaki I, Satoh SI, Suzuki Y, Shibuya M, Sugita K, Hidaka H (1990) Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365–372

    Article  PubMed  CAS  Google Scholar 

  • Auguet M, Delaflotte S, Chabrier PE, Braquet PC (1989) Comparative effects of endothelin and phorbol 12–13 dibutyrate in rat aorta. Life Sci 45:2051–2059

    Article  PubMed  CAS  Google Scholar 

  • Auguet M, Delaflotte S, Chabrier PE, Braquet PC (1993) Characterization of endothelin receptors mediating contraction and relaxation in rabbit saphenous artery and vein. Can J Physiol Pharmacol 71:818–823

    Article  PubMed  CAS  Google Scholar 

  • Awazu M, Parker RE, Harvie BR, Ichikawa I, Kon V (1991) Down-r\egulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17 [Suppl 7]:S500-S502

    Article  PubMed  CAS  Google Scholar 

  • Bacon CR, Davenport AP (1996) Endothelin receptors in human coronary artery and aorta. Brit J Pharmacol 117:986–992

    Article  CAS  Google Scholar 

  • Bath PMW, Martin JF (1991) Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolaemia. J Inter Med 230:313–317

    Article  CAS  Google Scholar 

  • Baydoun AR, Peers SH, Cirino G, Woodward B (1989) Effects of endothelin-1 on the rat isolated heart. J Cardiovasc Pharmacol 13 [Suppl 5]:S193-S196

    Article  PubMed  CAS  Google Scholar 

  • Baydoun AR, Peers SH, Cirino G, Woodward B (1990) Vasodilator action of endothelin-1 in the perfused rat heart. J Cardiovasc Pharmacol 15:759–763

    Article  PubMed  CAS  Google Scholar 

  • Bazil MK, Lappe RW, Webb RL (1992) Pharmacologic characterization of an endothelinA (ETA) receptor antagonist in conscious rats. J Cardiovasc Pharmacol 20:940–948

    Article  PubMed  CAS  Google Scholar 

  • Bdolah A, Wollberg Z, Ambar I, Kloog Y, Sokolovsky M, Kochva E (1989a) Disturbances in the cardiovascular system caused by endothelin and sarafotoxin. Biochem Pharmacol 38:3145–3146

    Article  PubMed  CAS  Google Scholar 

  • Benigni A, Orisio S, Gaspari F, Frusca T, Amuso G, Remuzzi G (1992) evidence against a pathogenic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 99:798–802

    Article  PubMed  CAS  Google Scholar 

  • Berrazueta JR, Bhagat K, Vallance P, MacAllister RJ (1997) Dose- and timedependency of the dilator effects of the endothelin antagonist, BQ-123, in the human. Brit J Clin Pharmacol 44:569–571

    Article  CAS  Google Scholar 

  • Berthiaume N, Yanagisawa M, Yanagisawa H, deWit D, D’Orleans-Juste P (1998) Pharmacology of endothelins in vascular circuits of normal heterozygous endothelin-A or endothelin-B knockout transgenic mice. J Cradiovasc Pharmacol 31 [Suppl 1]:S561-S564

    Article  CAS  Google Scholar 

  • Beyer ME, Slesak G, Hoffmeister HM (1996) Significance of endothelinB receptors for myocardial contractility and myocardial energy metabolism. J Pharmacol Exp Ther 278:1228–1234

    PubMed  CAS  Google Scholar 

  • Beyer ME, Slesak G, Brehm BR, Hoffmeister HM (1998) Hemodynamic and inotropic effects of the endothelin A antagonist BQ-610 in vivo. J Cardiovasc Pharmacol 31 [Suppl 1]:S258-S261

    Article  PubMed  CAS  Google Scholar 

  • Bialecki RA, Izzo NJ, Colucci WS (1989) endothelin-1 increases intracellular calcium mobilization but not calcium uptake in rabbit vascular smooth muscle cells. Biochem Biophys Res Commun 164:474–479

    Article  PubMed  CAS  Google Scholar 

  • Bigaud M, Pelton JT (1992) discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala 1,3,11,15]endothelin-l by BQ-123 in the anaesthetized rat. Br J Pharmacol 107:912–918

    Article  PubMed  CAS  Google Scholar 

  • Bohnemeier H, Pinto YM, Horkay F,Toth M, Juhasz-Nagy A, Orzechowski HD, Bohm M, Paul M (1998) Endothelin converting enzyme-1 mRNA expression in human cardiovascular disease. J Cardiovasc Pharmacol 31 (Suppl 1):S52-S54

    Article  PubMed  CAS  Google Scholar 

  • Bonvallet ST, Zamora MR, Hasunuma K, Sato K, Hanasato N, Anderson D, Sato K, Stelzner TJ (1994) BQ-123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 266:H1327-H1331

    PubMed  CAS  Google Scholar 

  • Borges R, Carter DV, Von Grafenstein H, Knight DE (1989a) Ionic requirements of the endothelin response in aorta and portal vein. Circ Res 65:265–271

    Article  PubMed  CAS  Google Scholar 

  • Borges R, Von Grafenstein H, Knight DE (1989b) Tissue selectivity of endothelin. Eur J Pharmacol 165:223–230

    Article  PubMed  CAS  Google Scholar 

  • Boulanger CM, Tanner FC, Beau ML, Han AWA, Werner A, Lüscher TF (1992) Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 70:1191–1197

    Article  PubMed  CAS  Google Scholar 

  • Brain SD, Tippins JR, Williams TJ (1988) endothelin induces potent microvascular constriction. Br J Pharmacol 95:1005–1007

    Article  PubMed  CAS  Google Scholar 

  • Brain SD, Crossman DC, Buckley TL, Williams TJ (1989) endothelin-1: demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol 13 [Suppl 5]:S147-S149

    Article  PubMed  CAS  Google Scholar 

  • Brooks DP, DePalma PD, Pullen M, Nambi P (1994) characterization of canine endothelin receptor subtypes and their function. J Pharmacol Exp Ther 268:1091–1097

    PubMed  CAS  Google Scholar 

  • Brown KD, Littlewood CJ (1989) endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. Biochem J 263:977–980

    PubMed  CAS  Google Scholar 

  • Bruneau BG, Piazza LA, de Bold AJ (1997) BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273:H2678-H2686

    PubMed  CAS  Google Scholar 

  • Brunner F, Kukovetz WR (1996) Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Circulation 94:1752–1761

    Article  PubMed  CAS  Google Scholar 

  • Burke SE, Lubbers NL and Gagne GD (1997) Selective antagonism of the ETA receptor reduces neointimal hyperplasia after balloon-induced injury in pigs. J Cardiovasc Pharmacol 30:33–41

    Article  PubMed  CAS  Google Scholar 

  • Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette JC, Godeau P, Cabrol C, Gandjbakhch I (1993) Endothelin-1 in primary pulmonary hypertension and the eisenmenger syndrome. Am J Cardiol 71:448–450

    Article  PubMed  CAS  Google Scholar 

  • Catelli De Carvalho MH, Nigro D, Scivoletto R, Barbiero HV, De Oliveira MA, De Nucci G, Fortes ZB (1990) comparison of the effect of endothelin on microvessels and macrovessels in Golblatt ii and deoxycorticosterone acetate-salt hypertensive rats. Hypertension 15 [Suppl I]:I68–171

    Article  Google Scholar 

  • Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JC (1990) Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol 259:F312-F317

    PubMed  CAS  Google Scholar 

  • Chandra S, Vickery-Clark L, Coatney RW, Phan L, Sarkar SK, Ohlstein EH (1998) Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of the endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation. Circulation 97:2252–2258

    Article  PubMed  CAS  Google Scholar 

  • Chapleau MW, Hajduczok G, Abboud FM (1992) suppression of baroreceptor discharge by endothelin at high carotid sinus pressure. Am J Physiol 263:R103-R108

    PubMed  CAS  Google Scholar 

  • Chua BHL, Krebs CJ, Chua CC, Diglio CA (1992) Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol 262:E412-E416

    PubMed  CAS  Google Scholar 

  • Clarke JG, Benjamin N, Larkin SW, Webb DJ, Davies GJ, Maseri A (1989) Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol 257:H2033-H2035

    PubMed  CAS  Google Scholar 

  • Clavell A, Stingo A, Margulies K, Lerman A, Underwood D, Burnett JC Jr (1993) Physiological significance of endothelin: its role in congestive heart failure. Circulation 87 ([Suppl V]:V45-V50

    CAS  Google Scholar 

  • Clerk A, Michael A, Sugden PH (1998) Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G-protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role for cardiac myocyte hypertrophy. J Cell Biol 142:523–535

    Article  PubMed  CAS  Google Scholar 

  • Clozel J-P, Clozel M (1989a) Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 65:1193–1200

    Article  PubMed  CAS  Google Scholar 

  • Clozel M, Clozel J-P (1989b) Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther 250:1125–1131

    PubMed  CAS  Google Scholar 

  • Clozel M, Gray GA, Breu V, Löffler B-M, Osterwalder R (1992) the endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biophys Res Commun 186:867–873

    Article  CAS  Google Scholar 

  • Clozel M, Breu V, Burri K, Cassal J-M, Fischli W, Gray GA, Hirth G, Löffler B-M, Müller M, Neidhart W, Ramutz H (1993a) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759–761

    Article  PubMed  CAS  Google Scholar 

  • Clozel M, Breu V, Gray GA, Löffler BM (1993b) In vivo pharmacology of Ro 46–2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology. J Cardiovasc Pharmacol 22 [Suppl 8]:S377-S379

    Article  PubMed  CAS  Google Scholar 

  • Clozel M, Watanabe H (1993) BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825–834

    Article  PubMed  CAS  Google Scholar 

  • Coceani F, Armstrong C, Kelsey L (1989) Endothelin is a potent constrictor of the lamb ductus arteriosus. Can J Physiol Pharmacol 67:902–904

    Article  PubMed  CAS  Google Scholar 

  • Coceani F, Kelsey L (1991) Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol 69:218–223

    Article  PubMed  CAS  Google Scholar 

  • Cocks TM, Faulkner NL, Sudhir K, Angus J (1989) reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur J Pharmacol 171:17–24

    Article  PubMed  CAS  Google Scholar 

  • Cosentino F, McMahon EG, Carter JS, Katusic ZS (1993) effect of the endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22 [Suppl 8]:S332-S335

    Article  PubMed  CAS  Google Scholar 

  • Criscione L, Nellis P, Riniker B,Thomann H, Burdet R (1990) Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers. Br J Pharmacol 99:31–36

    Article  Google Scholar 

  • Dashwood M, Turner M, Jacobs M (1989) Endothelin-1: contractile responses and autoradiographic localization of receptors in rabbit blood vessels. J Cardiovasc Pharmacol 13 [Suppl 5]:S183-S185

    Article  PubMed  CAS  Google Scholar 

  • Dashwood M, Barker SGE, Muddle JR, Yacoub MH, Martin JF (1993) [125I]-endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol 22 [Suppl 8]:S343-S347

    Article  PubMed  CAS  Google Scholar 

  • Dashwood MR, Allen SP, Luu TN, Muddle JR (1994) The effect of the ETA receptor antagonist, FR 139317, on [125I]-ET-1 binding to the atherosclerotic human coronary artery. Br J Pharmacol 112:386–389

    Article  PubMed  CAS  Google Scholar 

  • Dashwood MR, Mehta D, Izzat MB, Timm M, Bryan AJ, Angelini GD, Jeremy JY (1998) Distribution of endothelin-1 (ET) receptors (ETA and ETB) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts. Atherosclerosis 137:233–242

    Article  PubMed  CAS  Google Scholar 

  • Davenport AP, Ashby MJ, Easton P, Ella S, Bedorford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ (1990) A sensitive radioimmunoassay measuring endothe-lin-like immunoreactivity in human plasma: a comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 78:261–264

    PubMed  CAS  Google Scholar 

  • Davenport AP, Maguire JJ (1994) Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci 15:9–11

    Article  PubMed  CAS  Google Scholar 

  • Davies MG, Klyachkin ML, Kim JH, Hagen P-O (1993) Endothelin and vein bypass grafts in experimental atherosclerosis. J Cardiovasc Pharmacol 22 [Suppl8]:S348-S351

    Article  PubMed  CAS  Google Scholar 

  • De Nucci G, Thomas R, D’Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal from the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci (USA) 85:9797–9800

    Article  Google Scholar 

  • Doherty AM, Cody WL, He JX, Depue PL, Chang XM, Welch KM, Flynn MA, Reynolds EE, Ladouceur D, Davis LS, Keiser JA, Haleen SJ (1993) In vitro and in vivo studies with a series of hexapeptide endothelin antagonists. J Cardiovasc Pharmacol 22 [Suppl 8]:S98-S102

    Article  PubMed  CAS  Google Scholar 

  • Dohi Y, Hahn AWA, Boulanger C, Bühler FR, Lüscher TF (1992) Endothelin stimulated by angiotensin II augments contractility of SHR resistance arteries. Hypertension 19:131–137

    Article  PubMed  CAS  Google Scholar 

  • Domenech R, Macho P, González R, Huidobro-Toro JP (1991) Effect of endothelin on total and regional coronary resistance and on myocardial contractility. Eur J Pharmacol 192:409–416

    Article  PubMed  CAS  Google Scholar 

  • D’Orleans-Juste P, De Nucci G, Vane JR (1989) Endothelin-1 contracts isolated vessels independently of dihydropyridine-sensitive Ca2+ channel activation. Eur J Pharmacol 165:289–295

    Article  PubMed  Google Scholar 

  • Douglas SA, Hiley CR (1990) Endothelium-dependent vascular activities of endothe-lin-like peptides in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol 101:81–88

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Hiley CR (1991) endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16–21) and other endothelin-related peptides in the rat. Br J Pharmacol 104:311–320

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, James S, Hiley CR (1991) Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed. Br J Pharmacol 103:1441–1448

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Elliott JD, Ohlstein EH (1992) Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses. Eur J Pharmacol 221:315–324

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Vickery-Clark LM, Ohlstein EH (1993) Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123. Br J Pharmacol 108:418–421

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Gellai M, Ezekiel M, Ohlstein EH (1994a) BQ-123, a selective ndothelin (ETA) receptor antagonist, lowers blood pressure in different models of hypertension. J Hypertension 12:561–567

    Article  CAS  Google Scholar 

  • Douglas SA, Meek TD, Ohlstein EH (1994b) Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol Sci 15(9):313–316

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Vickery-Clark LM, Ohlstein EH (1994c) Functional evidence that angioplasty results in transient nitric oxide synthase induction. Eur J Pharmacol 255:81–89

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Vickery-Clark LM, Storer BL, Hart T, Louden C, Elliott JD, Ohlstein EH (1994d) A role for endogenous endothelin-1 in neointima formation following rat carotid artery balloon angioplasty: antiproliferative effects of the non-peptide endothelin receptor antagonist, SB 209670. Circ Res 75:190–197

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA, Beck GR Jr, Elliott JD, Ohlstein EH (1995a) Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein. Brit J Pharmacol 114:1529–1540

    Article  CAS  Google Scholar 

  • Douglas SA, Gellai M, Ezekiel M, Feuerstein GZ, Elliott JD, Ohlstein EH (1995b) Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension 25:818–822

    Article  PubMed  CAS  Google Scholar 

  • Douglas SA (1997) Clinical development of endothelin receptor antagonists. Trends Pharmacol Sci 18:408–412

    PubMed  CAS  Google Scholar 

  • Douglas SA, Ohlstein EH (1997) Signal transduction mechanisms mediating the vascular actions of endothelin. J Vasvc Res 34:152–164

    Article  CAS  Google Scholar 

  • Douglas SA, Nichols AJ, Feuerstein GZ, Elliott JD, Ohlstein EH (1998) SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog. J Cardiovasc Phramcol 31 [Suppl 1]:S99-S102

    Article  CAS  Google Scholar 

  • Dubin D, Pratt RE, Cooke JP, Dzau VJ (1989) endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1:150–153

    Google Scholar 

  • Eglen RM, Michel AD, Sharif NA, Swank SR, Whiting RL (1989) the pharmacological properties of the peptide, endothelin. Br J Pharmacol 97:1297–1307

    Article  PubMed  CAS  Google Scholar 

  • Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F (1994) phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134:222–228

    Article  PubMed  CAS  Google Scholar 

  • Elferink JG, de Koster BM (1996a) Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c. Chem Bio Int 101:165–174

    Article  CAS  Google Scholar 

  • Elferink JG, de Koster BM (1996b) The effect of endothelin-2 (ET-2) on migration and changes in cytosolic free calcium of neutrophils. Naunyn-Schmied Arch Pharmacol 353:130–135

    Article  CAS  Google Scholar 

  • Emori T, Hirata Y, Marumo F (1990) Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett 263:261–264

    Article  PubMed  CAS  Google Scholar 

  • Ercan ZS, Ilhan M, Kilinc M, Turker RK (1996) Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats. Pharmacology 53:234–240

    Article  PubMed  CAS  Google Scholar 

  • Ezra D, Goldstein RE, Czaja JF, Feuerstein GZ (1989) Lethal ischemia due to coronary endothelin in pigs. Am J Physiol 257:H339-H343

    PubMed  CAS  Google Scholar 

  • Ferrer P, Valentine M, Jenkins-West T (1995). Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J Cardiovasc Pharmacol 26:908–915

    Article  PubMed  CAS  Google Scholar 

  • Ferri C, Latorraca A, Catapano G, Greco F, Mazzoni A, Clerico A, Pedrinella R (1993) Increased plasma endothelin-1 immunoreactive levels in vasculitis: a clue to the use of endothelin-1 as a marker of vascular damage. J Hypertension 11 [Suppl 5]:S142-S143

    CAS  Google Scholar 

  • Ferro CJ, Haynes WG, Johnston NR, Lomax CC, Newby DE, Webb DJ (1997) Brit J Clin Pharmacol 44:377–383

    Article  CAS  Google Scholar 

  • Feuerstein GZ, Gu J-L, Ohlstein EH, Barone FC, Yue T-L (1994) Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection. Peptides 15:467–469

    Article  PubMed  CAS  Google Scholar 

  • Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P (1991) Effect of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol 104:797–804

    Article  PubMed  CAS  Google Scholar 

  • Filep JG, Foldes-Filep E, Rousseau A, Fournier A, Sirois P, Yano M (1992) Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol 219:343–344

    Article  PubMed  CAS  Google Scholar 

  • Filep JG, Skrobik Y, Fournier A, Foldes-Filep E (1996) Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. Br J Pharmacol 118:893–900

    Article  PubMed  CAS  Google Scholar 

  • Florijn KW, Derkx FHM, Visser W, Hofman JA, Rosmalen FMA, Wallenburg HCS, Schalekamp MADH (1991) Elevated plasma levels of endothelin in preeclampsia. J Hypertension 9 [Suppl 6]:S166-S167

    CAS  Google Scholar 

  • Foley PL, Caner HH, Kassell NF, Lee KS (1994) Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurg 34:108–113

    Article  CAS  Google Scholar 

  • Folta A, Joshua IG, Webb RC (1989) Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea-pig. Life Sci 45:2627–2635

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR, Part ML (1990) No major role for atrial natriuretic peptide in the vasoactive response to endothelin-1 in the spontaneously hypertensive rat. Eur J Pharmacol 180:153–159

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR, Part ML (1992) The role of nitric oxide in the regional effects of endothelin-1 in the rat. Br J Pharmacol 105:744–750

    Article  PubMed  CAS  Google Scholar 

  • Fu L-X, Sun X-Y, Hedner T, Feng Q-P, Liang Q-M, Hoebeke J, Hjalmarson A (1993) Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with chronic ischemic heart failure. J Cardiovasc Pharmacol 22:177–182

    Article  PubMed  CAS  Google Scholar 

  • Fukuda Y, Hirata Y, Yoshimi H, Kojima T, Kobayashi Y, Yanagisawa M, Masaki T (1988) Endothelin is a potent secretagonue for atrial natriuretic peptide in clutured rat atrial myocytes. Biochem Biophys Res Commun 155:167–172

    Article  PubMed  CAS  Google Scholar 

  • Fukue M, Ishikawa S, Miyauchi T, Onizuka M, Jerome EH (1994) No attenuation of hypoxic vasoconstriction by endothelin receptor blocker in perfused sheep lungs. FASEB J 8:A330

    Google Scholar 

  • Gallai V, Sarchielli P, Firenze C, Trequattr\ini A, Paciaroni M, Usai F, Palumbo R (1994) Endothelin-1 in migraine and tension-type headache. Acta Neurol Scand 89:47–55

    Article  PubMed  CAS  Google Scholar 

  • Garcia JL, Fernandez N, Garcia-Villalon AL, Monge L, Gomez B, Dieguez G (1996) Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 315:179–186

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S (1989) NG-monomethyl-L-arginine does not inhibit the hindquarters vasoactive action of endothelin-1 in conscious rats. Eur J Pharmacol 171:237–240

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Bennett T (1990a) Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br J Pharmacol 100:158–162

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Bennett T (1990b) Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol 99:107–112

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S (1990c) Regional haemodynamic changes during oral ingestion of NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 101:10–12

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Kemp PA, Bennett T (1990d) Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol 101:632–639

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Kemp PA, Bennett T (1991a) effects of nG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol 102:65–72

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Compton AM, Kemp PA, Bennett T, Foulkes R, Hughes B (1991b) Haemodynamic effects of human a-calcitonin gene-related peptide following administration of endothelin-1 or Nω-nitro-L-arginine methyl ester in conscious rats. Br J Pharmacol 103:1256–1262

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Kemp PA, March JE, Bennett T (1994) Effects of bosentan (Ro 47–0203), an etA-/ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br J Pharmacol 112:823–830

    Article  PubMed  CAS  Google Scholar 

  • Gardiner SM, Kemp PA, March JE, Bennett T, Davenport AP, Edvinsson L (1994) Effects of an ETA-receptor antagonist, FR 139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-l (6–21) in conscious rats. Br J Pharmacol 112:477–86

    Article  PubMed  CAS  Google Scholar 

  • Garjani A, Wainwright CL, Zeitlin IJ, Wilson C, Slee S-J (1995) Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 25:634–642

    Article  PubMed  CAS  Google Scholar 

  • Gass A, Flammer J, Linder L, Romerio SC, Gasser P, Haefeli WE (1997) Inverse correlation between endothelin-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 235:634–638

    Article  PubMed  CAS  Google Scholar 

  • Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New Eng J Med 328:1732–1739

    Article  PubMed  CAS  Google Scholar 

  • Giller T, Breu V, Valdenaire O, Clozel M (1997) Absence of ET(B)-mediated contraction in Piebald-lethal mice. Life Sci 61:255–263

    Article  PubMed  CAS  Google Scholar 

  • Godfraind T (1994) Endothelin receptors in human coronary arteries. Trends Pharmacol Sci 15:136–137

    Article  PubMed  CAS  Google Scholar 

  • Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA (1997) Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 96:3063–3071

    Article  PubMed  CAS  Google Scholar 

  • Grantham JA, Schirger JA, Williamson EE, Heublein DM, Wennberg PW, Kirchengast M, Münter K, Subkowski T, Burnett JC (1998) Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis. J Cardiovasc Pharmacol 31 [Suppl 1]:S22-S26

    Article  PubMed  CAS  Google Scholar 

  • Grover GJ, Sleph PG, Fox M, Trippodo NC (1992) Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther 263:1074–1082

    PubMed  CAS  Google Scholar 

  • Gu X-H, Casley DJ, Cincotta M, Nayler WG (1990) 125I-End othelin-l binding to brain and cardiac membranes from normotensive and spontaneously hypertensive rats. Eur J Pharmacol 177:205–209

    Article  PubMed  CAS  Google Scholar 

  • Guarda E, Katwa LC, Myers PR,Tyagi SC, Weber KT (1993) effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27:2130–2134

    Article  PubMed  CAS  Google Scholar 

  • Haak T, Jungmann E, Kasper-Dahm G, Ehrlich S, Usadel KH (1994) Elevated endothelin-1 levels in critical illness. Clin Invest 72:580–584

    CAS  Google Scholar 

  • Haegerstrand A, Hemsén A, Gillis C, Larsson O, Lundberg JM (1989) Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent constrictor effect. Acta Physiol Scand 137:541–542

    Article  PubMed  CAS  Google Scholar 

  • Han S-P, Knuepfer MM,Trapani AJ, Fok KF, Westfall TC (1990a) cardiac and vascular actions of sarafotoxin S6b and endothelin-1. Life Sci 46:767–775

    Article  PubMed  CAS  Google Scholar 

  • Hand MF, Haynes WG, Johnstone HA, Anderton JL, Webb DJ (1995) Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure. Kidney Int 48:806–813

    Article  PubMed  CAS  Google Scholar 

  • Harada M, Saito Y, Nakagawa O, Miyamoto Y, Ishikawa M, Kuwahara K, Ogawa E, Nakayama M, Kamitani S, Hamanaka I, Kajiyama N, Masuda I, Itoh H,Tanaka I, Nakao K (1997) Role of cardiac nonmyocytes in cyclical mechanical stretch-induced myocyte hypertrophy. Heart and Vessels 12:198–200

    PubMed  Google Scholar 

  • Harrison VJ, Randriantsoa A, Schoeffer P (1992) Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol 105:511–513

    Article  PubMed  CAS  Google Scholar 

  • Haug C, Koenig W, Hoeher M, Kochs M, Hombach V, Gruenert A, Osterhues, H. (1998) Direct enzyme immunometric measurement of plasma big endothelin-I concentrations and correlation with indicators of left ventricular function. Clin Chem 44:239–243.

    PubMed  CAS  Google Scholar 

  • Haynes WG, Webb DJ (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344:832–833

    Article  Google Scholar 

  • Haynes WG, Ferro CE, Webb DJ (1995a) Physiologic role of endothelin in maintenance of vascular tone in humans. J Cardiovasc Pharmacol 26 [Suppl 3]:S183-S185

    PubMed  CAS  Google Scholar 

  • Haynes WG, Strachan FE, Gray GA, Webb DJ (1995b) Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans. J Cardiovasc Pharmacol 26 [Suppl 3]:S40-S43

    PubMed  CAS  Google Scholar 

  • Haynes WG, Ferro, CJ, O’Kane KP, Somerville D, Lomax CC, Webb DJ (1996) Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93:1860–1870

    Article  PubMed  CAS  Google Scholar 

  • Hele DJ, Birell M, Bush RC (1995) Selective ETA and mixed ETA/ETB receptor antagonists inhibit balloon catheter-induced smooth muscle cell proliferation in the rat thoracic aorta. Br J Pharmacol 114:P199

    Google Scholar 

  • Helset E, Sildnes T, Seljelid R, Konopski ZS (1993) endothelin-1 stimulates human monocytes in vitro to release TNFα, IL-1? and IL-6. Mediat Inflamm 2:417–422

    Article  CAS  Google Scholar 

  • Helset E, Sildnes T, Konopski ZS (1994) endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotactic protein-1. Mediat Inflamm 3:155–160

    Article  CAS  Google Scholar 

  • Hieda HS, Gomez-Sanchez CE (1990) hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci 47:247–251

    Article  PubMed  CAS  Google Scholar 

  • Hiley CR, Douglas SA, Randall MD (1989) pressor effects of endothelin-1 and some analogs in the perfused superior mesenteric arterial bed of the rat. J Cardiovasc Pharmacol 13 [Suppl 5]:S197-S199

    Article  PubMed  CAS  Google Scholar 

  • Hiley CR, Patel KCR, Douglas SA (1993) effects of hypoxic perfusion on relaxation to endothelin peptides in the isolated perfused superior mesenteric arterial bed of the rat. Br J Pharmacol 108:155P

    Article  Google Scholar 

  • Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F (1997) Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis and renal cysts but not hypertension. J Clin Invest 99:1380–1389

    Article  PubMed  CAS  Google Scholar 

  • Hoffman A, Grossman E, Ȕhman P, Marks E, Keiser HR (1989a) endothelin induces an initial increase in cardiac output associated with selective vasodilation in rats. Life Sci 45:249–255

    Article  PubMed  Google Scholar 

  • Hu JR, Berninger UG, Lang RE (1988) endothelin stimulates atrial natriuretic peptide (ANP) release from rat atria. Eur J Pharmacol 158:177–178

    Article  PubMed  CAS  Google Scholar 

  • Hughes AD, Thom SA, Woodall N, Schachter M, Hair WM, Martin GN, Sever PS (1989) Human vascular responses to endothelin-1: observations in vivo and in vitro. J Cardiovasc Pharmacol 13 [Suppl 5]:S225-S228

    Article  PubMed  CAS  Google Scholar 

  • Igarashi Y, Aizawa Y, Tamura M, Ebe K, Yamaguchi T, Shibata A (1989) vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? Am Heart J 118:674–678

    Article  PubMed  CAS  Google Scholar 

  • Ino T, Ohkubo M, Shimazaki S, Akimoto K, Nishimoto K, Iwahara M, Yabuta K, Hosoda Y (1992) plasma endothelin concentration: relation with vascular resistance and comparison before and after balloon dilatation procedures. Eur J Pediatr 151:416–419

    Article  PubMed  CAS  Google Scholar 

  • Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91:4892–4896

    Article  PubMed  CAS  Google Scholar 

  • Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea-pig atria. Am J Physiol 255:H970-H973

    PubMed  CAS  Google Scholar 

  • Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209–215

    Article  PubMed  CAS  Google Scholar 

  • Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, Ohta Y, Marumo F (1994) Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 89:2198–2203

    Article  PubMed  CAS  Google Scholar 

  • Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M (1993) A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental vasospasm in dogs. Biochem Biophys Res Commun 195:969–975

    Article  PubMed  CAS  Google Scholar 

  • James AF, Urade Y, Webb RL, Karaki H, Umemura I, Fujitani Y, Oda K, Okada T, Lappe RW, Takai M (1993) IRL 1620, succinyl-[glu9 Ala11,15]-endothelin (8–21), a highly specific agonist of the ETB receptor. Cardiovasc Drug Rev 11:253–270

    Article  CAS  Google Scholar 

  • James AF, Xie LH, Fujitani Y, Hatashi S, Horie M (1994) Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1. Nature 370:252–253

    Article  Google Scholar 

  • Kamata K, Miyata N, Kasuya Y (1990) Effects of endothelin on the portal vein from spontaneously hypertensive and Wistar Kyoto rats. Gen Pharmacol 21:127–129

    Article  PubMed  CAS  Google Scholar 

  • Kamoi K, Sudo N, Ishibashi M, Yamaji T (1990) Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. New Engl J Med 323:1486–1487

    Article  PubMed  CAS  Google Scholar 

  • Kanno K, Hirata Y, Shichiri M, Marumo F (1991) Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication. J Cardiovasc Pharmacol 17 [Suppl 7]:S475-S476

    Article  PubMed  Google Scholar 

  • Kelso EJ, Spiers JP, McDermott BJ, Schofield CN, Silke B (1998) Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular myocytes. J Pharmacol Exp Ther 286:662–669

    PubMed  CAS  Google Scholar 

  • Khraibi AA, Heublein DM, Knox FG, Burnett JC Jr (1993) Increased plasma level of endothelin-1 in the okamoto spontaneously hypertensive rat. Mayo Clin Proc 68:42–46

    Article  PubMed  CAS  Google Scholar 

  • Kim S, Morimoto S, Koh E, Miyashita Y, Ogihara T (1989) Comparison of effects of a potassium channel opener, BRL34915, a specific potassium ionophore, valinomycin and calcium channel blockers on endothelin-induced vascular contraction. Biochem Biophys Res Commun 164:1003–1008

    Article  PubMed  CAS  Google Scholar 

  • Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O (1995) Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346:732–736

    Article  PubMed  CAS  Google Scholar 

  • Kirchengast M, Münter K (1998) Endothelin and restenosis. Cardiovasc Res 39: 550–555

    Article  PubMed  CAS  Google Scholar 

  • Kirilov G, Dakovska L, Borisova AM, Krivoshiev S, Nentchev N (1994) Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications. Horm Metab Res 26:119–120

    Article  PubMed  CAS  Google Scholar 

  • Kodama M, Kanaide H, Abe S, Hirano K, Kai H, Nakamura M (1989) Endothelin-induced Ca-independent contraction of the porcine coronary artery. Biochem Biophys Res Commun 160:1302–1308

    Article  PubMed  CAS  Google Scholar 

  • Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T (1989a) Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 256:R858-R866

    PubMed  CAS  Google Scholar 

  • Krum H, Gu A, Wilshire-Clement M, Sackner-Bernstein J, Goldsmith R, Medina N, Yushak M, Miller M, Packer M (1996) Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure. Am Heart J 131:337–341

    Article  PubMed  CAS  Google Scholar 

  • Krum H, Katz SD (1998) Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure. Am J Cardiol 81:355–358

    Article  PubMed  CAS  Google Scholar 

  • Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension: bosentan Hypertension Investigators. N Engl J Med 338:784–790

    Article  PubMed  CAS  Google Scholar 

  • Kurihara H, Yoshizumi M, Sugiyama T, Yamaoki K, Nagai R, Takaku F, Satoh H, Inui J, Yanagisawa M, Masaki T, Yazaki Y (1989) The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J Cardiovasc Pharmacol 13 [Suppl5]:S132-S137

    Article  PubMed  CAS  Google Scholar 

  • Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W-H, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703–710

    Article  PubMed  CAS  Google Scholar 

  • Kurose I, Miura S, Suematsu M, Fukumura D, Nagata H, Sekizuka E,Tsuchiya M (1991) Involvement of platelet-activating factor in endothelin-induced vascular smooth muscle cell contraction. J Cardiovasc Pharmacol 17 [Suppl 7]:S279-S283

    Article  PubMed  CAS  Google Scholar 

  • Kurose I, Miura S, Suematsu M, Fukumura,Tsuchiya M (1993) Mechanisms of endothelin-induced macromolecular leakage in microvascular beds of rat mesentery. Eur J Pharmacol 250:85–94

    Article  PubMed  CAS  Google Scholar 

  • Kusuhara M, Yamaguchi K, Ohnishi A, Abe K, Kimura S, Oono H, Hori S, Nakamura Y (1989) Endothelin potentiates growth factor-stimulated dna synthesis in swiss 3T3 cells. Jpn J Cancer Res 80:302–305

    Article  PubMed  CAS  Google Scholar 

  • Kusumoto K, Fujiwara S, Awane Y, Watanabe T (1993) The role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 22 (Suppl. 8):S339-S342

    Article  PubMed  CAS  Google Scholar 

  • Kuwaki T, Kurihara H, Cao WH, Kurihara Y, Unekawa M, Yazaki Y, Kumada M (1997) Physiological role for brain endothelin in the central and autonomic control: from neuron to knockout mouse. Prog Neurobiol 51:545–579

    Article  PubMed  CAS  Google Scholar 

  • Kwok CF, Chen ML, Ho LT (1993) Insulin increases the endothelin-1 receptor in cultured rat aortic smooth muscle cells. Diabetelog 36 (Suppl. 1):A203

    Google Scholar 

  • Ladouceur DM, Flynn MA, Keiser JA, Reynolds E, Haleen SJ (1993) ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction. Biochem Biophys Res Commun 196:209–215

    Article  PubMed  CAS  Google Scholar 

  • Lam H-C, Takahashi K, Ghatei MA, Warrens AN, Rees AJ, Bloom SR (1991) Immunoreactive endothelin in human plasma, urine, milk and saliva. J Cardiovasc Pharmacol 17 [Suppl 7]:S390-S393

    Article  PubMed  CAS  Google Scholar 

  • Larivière R, Thibault G, Schiffrin E (1993) Increase endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertension but not in spontaneously hypertensive rats. Hypertension 21:294–300

    Article  PubMed  Google Scholar 

  • Larkin SW, Clarke JG, Keogh BE, Araujo L, Rhodes C, Davies GJ, Taylor KM, Maseri A (1989) Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 64:956–958

    Article  PubMed  CAS  Google Scholar 

  • Lauder H, Sellers LA, Fan TP, Feniuk W, Humphrey PP (1997) Somatostatin sst5 inhibition of receptor-mediated regeneration of rat aortic vascular smooth muscle cells. Brit J Pharmacol 122:663–670

    Article  CAS  Google Scholar 

  • Lawrence E, Brain SD (1992) Altered microvascular reactivity to endothelin-1, endothelin-3 and Nω-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus. Br J Pharmacol 106:1035–1040

    Article  PubMed  CAS  Google Scholar 

  • Leadley RJ, Lee P, Erickson LA, Shebuski RJ (1993) The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery. J Cardiovasc Pharmacol 22 [Suppl 8]:S199-S203

    Article  PubMed  CAS  Google Scholar 

  • Lee JY, Warner RB, Adler AL, Opgenorth TJ (1994) Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat. Pharmacology 49:319–324

    Article  PubMed  CAS  Google Scholar 

  • Lee ME, DeLa Monte SM, Ng SC, Bloch KD, Quertermous T (1990) Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest 86:141–147

    Article  PubMed  CAS  Google Scholar 

  • Lee S-Y, Lee CY, Chen YM, Kochva E (1986) Coronary vasospasm as the primary cause of death due to the venom of the burrowing asp, Atractaspis engaddensis. Toxicon 24:285–291

    Article  PubMed  Google Scholar 

  • Lee TS, Chao T, Hu K-Q, King GL (1989) Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochem Biophys Res Commun 162:381–386

    Article  PubMed  CAS  Google Scholar 

  • Lembeck F, Decrinis M, Pertl C, Amann R, Donnerer J (1989) Effects of endothelin on the cardiovascular system and on smooth muscle preparations in different species. Naunyn-Schmiedeberg’s Arch Pharmacol 340:744–751

    CAS  Google Scholar 

  • Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997–1001

    Article  PubMed  CAS  Google Scholar 

  • Leskinen H, Vuolteenaho O, Ruskoaho H (1997) Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release. Circ Res 80:114–123

    Article  PubMed  CAS  Google Scholar 

  • Le Monnier De Gouville A-C, Lippton HL, Cavero I, Summer WR, Hyman AL (1989) Endothelin — a new family of endothelium-derived peptides with widespread biological properties. Life Sci 45:1499–1513

    Article  PubMed  Google Scholar 

  • Liefeldt L, Bocker W, Schonfelder G, Zintz M, Paul M (1995) Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene. J Cardiovasc Pharmacol 26 [Suppl 3:S32-S33

    Google Scholar 

  • Liu J, Casley DJ, Nayler WG (1989) Ischaemia causes externalization of endothelin1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun 164:1220–1225

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Chen R, Casley DJ, Nayler WG (1990a) Ischaemia and reperfusion increase 125I-labelled endothelin-1 binding in rat cardiac membranes. Am J Physiol 258:H829-H835

    PubMed  CAS  Google Scholar 

  • Liu J, Gu X-H, Casley DJ, Nayler WG (1990b) Reoxygenation, but neither hypoxia nor intermittent ischaemia, increases [125I]endothelin-l binding to rat cardiac membranes. J Cardiovasc Pharmacol 15:436–443

    Article  PubMed  CAS  Google Scholar 

  • Lodge NJ, Halaka NN (1993) Endothelin receptor subtypes(s) in rabbit jugular vein smooth muscle. J Cardiovasc Pharmacol 22 [Suppl 8]:S140-S143

    Article  PubMed  CAS  Google Scholar 

  • Loesch A, Milner P, Anglin SC, Crowe R, Miah S, McEwan JR, Burnstock G (1997) Ultrastructural localisation of nitric oxide sythase, endothelin and binding sites for lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury. J Anatomy 190:93–104

    Article  CAS  Google Scholar 

  • Löffler B-M, Roux S, Kalina B, Clozel M, Clozel J-P (1993) Influence of congestive heart failure on endothelin levels and receptors in rabbits. J Mol Cell Cardiol 25:407–416

    Article  PubMed  Google Scholar 

  • Lopez JAG, Armstrong ML, Piegors DJ, Heistad DD (1990) Vascular responses to endothelin-1 in atherosclerotic primates. Artherosclerosis 10:1113–1118

    CAS  Google Scholar 

  • Lopez Farré A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Montón M, Rivas F, Gallego MJ, Egido J, Casado S, Caramelo C (1993) Effect of endothelin on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88:1166–1171

    Article  PubMed  Google Scholar 

  • Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ (1996) Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 94:2131–2137

    Article  PubMed  CAS  Google Scholar 

  • Lüscher TF, Seo B-G, Bühler FR (1993) Potential role of endothelin in hypertension: controversy on endothelin in hypertension. Hypertension 21:752–757

    Article  PubMed  Google Scholar 

  • Maccumber MW, Ross CA, Glaser BM, Snyder SM (1989) Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86:7285–7289

    Article  PubMed  CAS  Google Scholar 

  • MacLean MR, Hiley CR (1989) Blood pressure changes induced by [Ala1,3,11,15]endothelin in pithed rats: effects of lowering ventilation volume. Br J Pharmacol 97:529P

    Article  Google Scholar 

  • MacLean MR, Randall MD, Hiley CR (1989) Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat. Br J Pharmacol 98:1055–1065

    Article  PubMed  CAS  Google Scholar 

  • MacLean MR, McGrath JC (1990) Effects of pre-contraction with endothelin-1 on α2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol 101:205–211

    Article  PubMed  CAS  Google Scholar 

  • MacLean MR, MacKenzie JF, Docherty CC (1998) Heterogeneity of endothelin-B receptors in rabbit pulmonary resistance arteries. J Cardiovasc Pharmacol 31 [Suppl 1]:S115-S118

    Article  PubMed  Google Scholar 

  • Magga J, Vuolteenaho O, Marttila M, Ruskoaho H (1997) Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of the mixed ETA/ETB and ATl receptor antagonists in vivo and in vitro. Circulation 96:3053–3062

    Article  PubMed  CAS  Google Scholar 

  • Margulies KB, Hildebrand FL, Lerman A, Perrella MA, Burnett JC (1990) Increased endothelin in experimental heart failure. Circulation 82:2226–2230

    Article  PubMed  CAS  Google Scholar 

  • Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchart J-C (1991) Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 293:127–130

    Article  PubMed  CAS  Google Scholar 

  • Masaki T (1993) Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Rev 14:256–268

    CAS  Google Scholar 

  • Masaki T, Vane JR,Vanhoutte PM (1994) International union of pharmacology nomenclature of endothelin receptors. Pharmacol Rev 46:137–142

    PubMed  CAS  Google Scholar 

  • Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K (1989) Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2:1402

    Article  PubMed  CAS  Google Scholar 

  • Matsuyama K, Saito Y, Nakao K, Jougasaki M, Okumura K, Yasue H, Imura H (1991) Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 68:991–995

    Article  PubMed  CAS  Google Scholar 

  • McCarron RM, Wang L, Stanimirovic DB, Spatz M (1993) Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 156:31–34

    Article  PubMed  CAS  Google Scholar 

  • McKenna CJ, Burke SE, Opgenorth TJ, Padley RJ, Camrud LJ, Camrud AR, Johnson J, Carlson PJ, Lerman A, Holmes DR, Schwartz RS (1998) Selective ETA receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. Circulation 97:2551–2556

    Article  PubMed  CAS  Google Scholar 

  • McMahon EG, Palomo MA, Moore WM (1991) Phosphoramidon blocks the pressor activity of big endothelin (1–39) and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol 17 [Suppl 7]:S29-S33

    Article  PubMed  CAS  Google Scholar 

  • McMurdo L, Lidbury PS, Corder R, Thiemermann C, Vane JR (1993) Heterogenous receptors mediate endothelin-1-induced changes in blood pressure, hematocrit, and platelet aggregation. J Cardiovasc Pharmacol 22 [Suppl 8]:S185-S188

    Article  PubMed  CAS  Google Scholar 

  • McMurdo L, Thiemermann C, Vane JR (1994) The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischemia and reperfusion. Br J Pharmacol 112:75–80

    Article  PubMed  CAS  Google Scholar 

  • Meyer P, Flammer J, Lüscher TF (1993) Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci 34:3614–3621

    PubMed  CAS  Google Scholar 

  • Miasiro N, Yamamoto H, Kanaide H, Nakamura M (1988) Does endothelin mobilize calcium from intracellular store sites in rat aortic vascular smooth muscle cells in primary culture? Biochem Biophys Res Commun 156:312–317

    Article  PubMed  CAS  Google Scholar 

  • Miki S, Takeda K, Kiyama M, Hatta T, Morimoto S, Kawa T, Itoh H, Nakata T, Sasaki S, Nakagawa M (1998) Augmented response of endothelin-A and endothelin-B receptor stimulation in coronary arteries of hypertensive hearts. J Cardiovasc Pharmacol 31 [Suppl 1]:S94-S98

    Article  PubMed  CAS  Google Scholar 

  • Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, Yazaki Y (1997) Endothelin coverting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 95:221–230

    Article  PubMed  CAS  Google Scholar 

  • Mir AK, Berthold H, Scholtysik GE, Fozard JR (1989) Cardiovascular effects of endothelin 1 in pithed spontaneously hypertensive rats: evaluation of its mechanism^) of action. Naunyn-Schmiedeberg’s Arch Pharmacol 340:424–430

    Article  CAS  Google Scholar 

  • Miyauchi T, Ishikawa T, Tomobe Y, Yanagisawa M, Kimura S, Sugishita Y, Ito I, Goto K, Masaki T (1989a) Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 14:427–434

    Article  PubMed  CAS  Google Scholar 

  • Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki M, Fuzino M, Ajisaka R, Goto K, Masaki T (1989b) Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2:53–54

    Article  PubMed  CAS  Google Scholar 

  • Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K (1993) Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73:887–897

    Article  PubMed  CAS  Google Scholar 

  • Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, Masaki T, deWit D, Yanagisawa M, Kimura S (1997) Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Brit J Pharmacol 120:1427–1430

    Article  CAS  Google Scholar 

  • Molenaar P, O’Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538

    Article  PubMed  CAS  Google Scholar 

  • Morbidelli L, Orlandi C, Maggi CA, Ledda F, Ziche M (1995) Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol 269:H686-H695

    PubMed  CAS  Google Scholar 

  • Morel DR, Lacroix JS, Hemsen A, Steinig DA, Pittet J-F, Lundberg JM (1989) Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 167:427–428

    Article  PubMed  CAS  Google Scholar 

  • Moreland S, McMullen DM, Delaney CL, Lee VG, Hunt JT (1992) Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem Biophys Res Commun 184:100–106

    Article  PubMed  CAS  Google Scholar 

  • Moreland S, McMullen D, Abboa-Offei B, Seymour A (1994) Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br J Pharmacol 112:704–708

    Article  PubMed  CAS  Google Scholar 

  • Morita H, Kurihara H, Kurihara Y, Shindo T, Kuwaki T, Kumada M, Yazaki Y (1998) Systemic and renal response to salt loading in endothelin-1 knockout mice. J Cardiovasc Pharmacol 31 [Suppl 1]:S557-S560

    Article  PubMed  CAS  Google Scholar 

  • Mortensen LH, Fink GD (1992) Captopril prevents chronic hypertension produced by infusions of endothelin-1 in rats. Hypertension 19:676–680

    Article  PubMed  CAS  Google Scholar 

  • Mosqueda-Garcia R, Inagami T, Appalsamy M, Sugiura M, Robertson RM (1992) Endothelin as a neuropeptide. Cardiovascular effects in the brainstem of normotensive rats. Circ Res 72:20–35

    Article  Google Scholar 

  • Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B,Thuillez C (1997) The role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96:1976–1982

    Article  PubMed  CAS  Google Scholar 

  • Münter K, Hergenröder S, Unger L, Kirchengast M (1996) Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett 6:90–92

    Google Scholar 

  • Nakayama K, Ishigai Y, Uchida H, Tanaka Y (1991) Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Br J Pharmacol 104:978–986

    Article  PubMed  CAS  Google Scholar 

  • Nakayama T, Numata Y, Kawada M, Kurokawa H, Nakamura T, Hasimoto K (1993) Hyperpermeability of abdominal capillary vessels to endothelin-1 in patients with diabetes mellitus. J Cardiovasc Pharmacol 22 [Suppl 8]:S360-S363

    Article  PubMed  CAS  Google Scholar 

  • Naito S, Shimizu S, Maeda S, Wang J, Paul R, Fagin JA (1998) ET-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. Am J Physiol 274:C472-C480

    PubMed  CAS  Google Scholar 

  • Nelson RA, Burke SE, Opgenorth T (1994) Endothelin receptor antagonist FR 139317 reduces infarct size in a rabbit coronary artery occlusion model. FASEB J 8:A854

    Google Scholar 

  • Nemoto S, Sheng Z, Lin A (1998) Opposing effects of Jun kinase and p38 mitogenactivated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 18:3518–3526

    PubMed  CAS  Google Scholar 

  • Neubauer S, Ertl G, Haas U, Pulzer F, Kochsiek K (1990) Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharmacol 16:1–8

    Article  PubMed  CAS  Google Scholar 

  • Newby DE, Flint LL, Fox KA, Boon NA, Webb DJ (1998) Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X. J Am Coll Cardiol 31:1585–1590

    Article  PubMed  CAS  Google Scholar 

  • Nichols AJ, Koster PF, Ohlstein EH (1990) The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog. Br J Pharmacol 99:597–601

    Article  PubMed  CAS  Google Scholar 

  • Niranjan V,Telemaque S, deWit D, Gerard RD, Yanagisawa M (1996) Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats. J Clin Invest 98:2364–2372

    Article  PubMed  CAS  Google Scholar 

  • Nisell H, Wolff K, Hemsen A, Lindblom B, Lunell NO, Lundberg JM (1991) Endothelin, a vasoconstrictor important to the uteroplacental circulation in pre-eclampsia. J Hypertens 9(Suppl 6):S168-S169

    CAS  Google Scholar 

  • Nishikibe M, Tsuchida S, Okada M, Fukuroda T, Shimamoto K, Yano M (1993) Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci 52:717–724

    Article  PubMed  CAS  Google Scholar 

  • Noiri E, Hu Y, Bahou WF, Keese CR, Giaever I, Goligorsky MS (1997) Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 272:1747–1752

    Article  PubMed  CAS  Google Scholar 

  • Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD (1991) Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165:724–727

    PubMed  CAS  Google Scholar 

  • Nugent AC, McGurk C, Hayes JR, Johnston GD (1996) Impaired vasoconstriction to endothelin-1 in patients with NIDDM. Diabetes 45:105–107

    Article  PubMed  CAS  Google Scholar 

  • Ohlstein EH, Horohonich S, Hay DWP (1989) Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther 250:548–550

    PubMed  CAS  Google Scholar 

  • Ohlstein EH, Vickery L, Sauermelch C, Willette RN (1990) Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters. Am J Physiol 259:H1835-H1841

    PubMed  CAS  Google Scholar 

  • Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung C-P (1992) The selective endothelin ETA receptor antagonist BQ-123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol 225:347–350

    Article  PubMed  CAS  Google Scholar 

  • Ohlstein EH, Douglas SA (1993) Endothelin-1 modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Develop Res 29:108–128

    Article  CAS  Google Scholar 

  • Ohlstein EH, Douglas SA, Ezekiel M, Gellai M (1993) Antihypertensive effects of the endothelin antagonist BQ-123 in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 22 [Suppl 8]:S321-S324

    Article  PubMed  CAS  Google Scholar 

  • Ohlstein EH, Beck G, Douglas SA, Nambi P, Gleason JG, Ruffolo RR Jr, Feuerstein GZ, Elliott JD (1994a) Non-peptide endothelin receptor antagonists. ii: pharmacological characterization of SB 209670. J Pharmacol Exp Ther. 271:762–768

    PubMed  CAS  Google Scholar 

  • Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, Peishoff CE, Bean JW, Eggleston DS, Elshourbagy NA, Kumar C, Lee JA, Brooks DP, Ruffolo RR Jr, Feuerstein GZ, Weinstock J, Gleason JG, Elliott JD (1994b) SB 209670, rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci USA 91:8052–8056

    Article  PubMed  CAS  Google Scholar 

  • Ohlstein EH, Douglas SA, Brooks DP, Hay DWP, Feuerstein GZ, Ruffolo RR Jr (1995) Functions mediated by peripheral endothelin receptors. In Endothelin receptors: from the gene to the human. Ed Ruffolo RR Jr. ppl09–186. CRC Press, Boca Raton, FL.

    Google Scholar 

  • Ohlstein EH, Arleth AJ, Storer B, Romanic AM (1998) Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells. J Mol Cell Cardiol 30:167–173

    Article  PubMed  CAS  Google Scholar 

  • Ohno A, Naruse M, Kato S, Hosaka M, Karuse K, Demura H (1992) Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensive rats. J Hypertension 10:781–785

    Article  CAS  Google Scholar 

  • Okada K, Nishida Y, Murakami H, Sugimoto I, Kosaka H, Morita H, Yamashita C, Okada M (1998) Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a non selective endothelin receptor antagonist. Circulation 97:2346–2351

    Article  PubMed  CAS  Google Scholar 

  • Ono K,Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y, Satake M (1994) Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370:252–253

    Article  Google Scholar 

  • Oliver FJ, De La Rubia G, Feener E (1991) Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 266:23251–23256

    PubMed  CAS  Google Scholar 

  • Okamoto Y, Ninomiya H, Masaki T (1998) Posttranslational modifications of endothelin receptor type B. Trends Cardiovasc Med 8:327–329

    Article  PubMed  CAS  Google Scholar 

  • Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T (1998) Endothelininduced apoptosis of A375 human melanoma cells. J Biol Chem 273:12584–12592

    Article  PubMed  CAS  Google Scholar 

  • Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G (1994) Rat aortic smooth muscle cells isolated from different layers at different times after endothelial denudation shows distinct biological features in vitro. Arterioscler Thromb 14:982–989

    Article  PubMed  CAS  Google Scholar 

  • Otsuka A, Mikami H, Katahira K, Tsunetoshi T, Kohara K, Minamitani K, Moriguchi A, Ogihara T (1990a) Haemodynamic effect of endothelin, a novel potent vasoconstrictor in dogs. Clin Exp Pharmacol Physiol 17:351–360

    Article  PubMed  CAS  Google Scholar 

  • Ouchi Y, Kim S, Souza AC, Iijima S, Hattori A, Orimo H, Yoshizumi M, Kurihara H, Yazaki Y (1989) Central effect of endothelin on blood pressure in conscious rats. Am J Physiol 256:H1747-H1751

    PubMed  CAS  Google Scholar 

  • Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B, Heinz G, Maurer G (1996) Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 27:633–641

    Article  PubMed  CAS  Google Scholar 

  • Packer M, Caspi A, Charlton V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Massie B, McMurray J, Rizzon P, Swedberg K (1998) Multicenter, double-blind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure: results of the REACH-1 trial. Circulation 98:13

    Article  Google Scholar 

  • Panek RL, Major TC, Hingorani GP, Doherty AM, Taylor DG, Rapundalo ST (1992) Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem Biophys Res Commun 184:566–571

    Article  Google Scholar 

  • Pernow J, Hemsén A, Hallén A, Lundberg JM (1990) Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig. Acta Physiol Scand 140:311–312

    Article  PubMed  CAS  Google Scholar 

  • Pierre LN, Davenport AP (1998) Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Brit J Pharmacol 124:499–506

    Article  CAS  Google Scholar 

  • Plumpton C, Haynes WG, Webb DJ, Davenport AP (1995) Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. J Cardiovasc Pharmacol 26 [Suppl3]:S34-S36

    PubMed  CAS  Google Scholar 

  • Ponicke K, Heinroth-Hoffmann I, Becker K, Brodde OE (1997) Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin and non-myocyte cells. Brit J Pharmacol 121:118–124

    Article  CAS  Google Scholar 

  • Porat O, Neumann D, Zamir O, Nachshon S, Feigin E, Cohen J, Zamir N (1996) Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium. J Pharmacol Exp Ther 276:1162–1168

    PubMed  CAS  Google Scholar 

  • Porter KE, Olojugba DH, Masood I, Pemberton M, Bell PR, London NJ (1998) Endothelin B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein. J Vasc Surg 28:695–701

    Article  PubMed  CAS  Google Scholar 

  • Pousset F, Isnard R, Lechat P, Kalotka H, Carayon A, Maistre G, Escolano S, Thomas D, Komajda M (1997) Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 18:254–258

    Article  PubMed  CAS  Google Scholar 

  • Prat L, Carrió I, Roca M, Riambau V, Berné L, Estorch M, Ferrer I, Garcia C (1993) Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-l accumulation in experimental arterial wall injury. Eur J Nucl Med 20:1141–1145

    PubMed  CAS  Google Scholar 

  • Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mikami H, Ogihara T,Suzuki N (1990) Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 169:973–977

    Article  PubMed  CAS  Google Scholar 

  • Randall MD, Douglas SA, Hiley CR (1989) Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol 98:685–699

    Article  PubMed  CAS  Google Scholar 

  • Randall MD (1991) Vascular activities of the endothelins. Pharmacol Ther 50:73–93

    Article  PubMed  CAS  Google Scholar 

  • Raschack M, Juchelka F, Rozek-Schaefer G (1998) The endothelin-A antagonist, LU 135252, suppresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling. J Cardiovasc Pharmacol 31 [Suppl 1]: S145-S148

    Article  PubMed  CAS  Google Scholar 

  • Ravalli S, Szabolcs M, Albala A, Michler RE, Cannon PJ (1996) Increased immunore-active endothelin-1 in human transplant coronary artery disease. Circulation 94:2096–2102

    Article  PubMed  CAS  Google Scholar 

  • Rebello S, Roy S, Saxena PR, Gulati A (1995) Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors. Brain Res 676:141–150

    Article  PubMed  CAS  Google Scholar 

  • Reiser G (1990) Endothelin and a Ca2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide. Br J Pharmacol 101:722–726

    Article  PubMed  CAS  Google Scholar 

  • Resink TJ, Scott-Burden T, Bühler FR (1990b) Activation of multiple signal transduction pathways by endothelin in cultured human vascular smooth muscle cells. Eur J Biochem 189:415–421

    Article  PubMed  CAS  Google Scholar 

  • Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS,Simpson PC (1996) Alphal-adrenergic receptor subtype mRNAs are differentially regulated by alphal-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alphalB and alphalD but induction of alpha 1C. J Biol Chem 271:5839–5843

    Article  PubMed  CAS  Google Scholar 

  • Roux S, Loffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP (1995) The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78–85

    Article  PubMed  CAS  Google Scholar 

  • Rubanyi GM (1992) Endothelium-derived vasoconstrictor factors: an overview. In: Ryan US, Rubanyi GM (eds) Endothelial regulation of vascular tone, Marcel Dekker Inc, New York, pp. 375–386

    Google Scholar 

  • Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH (1989) Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet 2:747

    Article  PubMed  CAS  Google Scholar 

  • Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y (1996) Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384:353–355

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Oka M, Hasunuma K, Ohnishi M, Sato K, Kira S (1995) Effects of separate and combined ETA and ETB blockade on ET-1-induced constriction in perfused rat lungs. Am J Physiol 269:L668-L672

    PubMed  CAS  Google Scholar 

  • Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M, Mashiach S (1992) Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 166:624–628

    PubMed  CAS  Google Scholar 

  • Schiffrin EL, Turgeon A, Deng LY (1997) Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol 121:935–940

    Article  PubMed  CAS  Google Scholar 

  • Schiffrin EL (1998) Endothelin and endothelin antagonists in hypertension. J Hypertension 16:1891–1895 Schroeder RL, Jeiser JA, Cheng XM, Haleen SJ (1998) PD 142893, SB 209670 and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ETB-receptor activity in the rat. J Cardiovasc Pharmacol 32:935–943

    Article  Google Scholar 

  • Seo B, Oemar BS, Siebenmann R, Von Segesser L, Lüscher TF (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.Circulation 89:1203–1208

    Article  PubMed  CAS  Google Scholar 

  • Serradeil-Le Gal C, Herbert JM, Garcia C, Boutin M, Maffrand JP (1991) Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin. Peptides 12:575–579

    Article  PubMed  CAS  Google Scholar 

  • Shah AM (1994) Endothelin secretion by endocardial endothelial cells. Cardiovasc Res 28:722–1994

    Article  PubMed  CAS  Google Scholar 

  • Shah AM, Lewis MJ, Henderson AH (1989) Inotropic effects of endothelin in ferret ventricular myocardium. Eur J Pharmacol 163:365–367

    Article  PubMed  CAS  Google Scholar 

  • Shah AM, Lewis MJ (1993) Modulation of myocardial contraction by endocardial and coronary vascular endothelium. Trends Cardiovasc Med 3:98–103

    Article  PubMed  CAS  Google Scholar 

  • Shichiri M, Kato H, Marumo F, Hirata Y (1998a) Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 30:1198–1203

    Article  Google Scholar 

  • Shichiri M, Marumo F, Hirata Y (1998b) Endothelin-B receptor-mediated suppression of endothelial apoptosis. J Cardiovasc Pharmacol 31 [Suppl 1]:S138-S141

    Article  PubMed  CAS  Google Scholar 

  • Shichiri M, Sadivy JM, Marumo F, Hirata Y (1998c) Endothelin-1 is a potent survival factor for c-Myc-dependent. Mol Endocrinol 12:172–180

    Article  PubMed  CAS  Google Scholar 

  • Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH,Chien KR (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265:20555–20562

    PubMed  CAS  Google Scholar 

  • Skvorak JP, Nazian SJ, Dietz JR (1995) Endothelin acts as a paracrine regulator of stretch-induced atrial natriuretic peptide release. Am J Physiol 269:R1093-R1098

    PubMed  CAS  Google Scholar 

  • Simonson MS, Jones JM, Dunn MJ (1992) Cytosolic and nuclear signaling by endothelin peptides: mesangial response to glomerular injury. Kidney Int 41:542–545

    Article  PubMed  CAS  Google Scholar 

  • Simonson MS, Herman WH (1993) Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J Biol Chem 268:9347–9357

    PubMed  CAS  Google Scholar 

  • Simonson MS, Emancipator SN, Knauss T, Hricik DE (1998) Elevated neointimal endothelin-1 in transplantation-associated arteriosclerosis of renal graft recipients.Kidney Int 54:960–971

    Article  PubMed  CAS  Google Scholar 

  • Smits P, Hofman H, Rosmalen F, Wollersheim H, Thein T (1991) Endothelin-1 in patients with Reynaud’s phenomenon. Lancet: 337:236

    Article  PubMed  CAS  Google Scholar 

  • Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T (1992) Pharmacological profile of FR 139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther 264:1040–1144

    Google Scholar 

  • Spokes RA, Ghatei MA, Bloom SR (1989) Studies with endothelin-3 and endothelin-1 on rat blood pressure and isolated tissues: evidence for multiple endothelin receptor subtypes. J Cardiovasc Pharmacol 13 [Suppl 5]:S191-S192

    Article  PubMed  CAS  Google Scholar 

  • Stein PD, Hunt JT, Floyd DM, Moreland S, Dickinson KEJ, Mitchell C, Liu EC-K, Webb ML, Murugesan N, Dickey J, McMullen D, Zhang R, Lee VG, Serafino R, Delaney C, Schaeffer TR, Kozlowski M (1994) The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(Dimethylamino)-N-(3,4,-dimethyl-5-isoxazolyl)-l-naphthalene-sulfonamide. J Med Chem 37:329–331

    Article  PubMed  CAS  Google Scholar 

  • Stewart DJ, Levy RD, Cernacek P, Langleben D (1991) Increased plasma endothelin1 in pulmonary hypertension: marker or mediator of disease? Ann Int Med 114:464–469

    PubMed  CAS  Google Scholar 

  • Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ (1999) Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 33:581–585

    Article  PubMed  CAS  Google Scholar 

  • Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T, Karaki H (1993) A novel subtype of endothelin B receptor-mediating contraction in swine pulmonary vein. Life Sci 53:431–437

    Article  PubMed  CAS  Google Scholar 

  • Sudjarwo SA, Hori M, Tanaka T, Matsuda Y, Okada T, Karaki H (1994) Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction.Biochem Biophys Res Commun 200:627–633

    Article  PubMed  CAS  Google Scholar 

  • Sugiura M, Inagami T, Hare GMT, Johns JA (1989a) Endothelin action: inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun 158:170–176

    Article  PubMed  CAS  Google Scholar 

  • Sugiura M, Inagami T, Kon V (1989b) Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161:1220–1227

    Article  PubMed  CAS  Google Scholar 

  • Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS (1992) Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br J Pharmacol 107:858–860

    Article  PubMed  CAS  Google Scholar 

  • Sunnergren KP, Word RA, Sambrook JF, Macdonald PC, Casey ML (1990) Expression and regulation of endothelin precursor mRNA in a vascular human amnion. Mol Cell Endocrinol 68:R7-R14

    Article  PubMed  CAS  Google Scholar 

  • Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, Fujino M (1990b) Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 167:941–947

    Article  PubMed  CAS  Google Scholar 

  • Suzuki T, Tsuruda A, Katoh S, Kubodera A, Mitsui Y (1997) Purification of endothelin from a conditioned medium of cardiac fibroblastic cells using beating rate assay of myocytes cultured in a serum-free medium. J Mol Cell Cardiol 29:2087–2093

    Article  PubMed  CAS  Google Scholar 

  • Tahara A, Kohno M, Yanagi S, Itagane H, Toda I, Akioka K, Teragaki M, Yasuda M, Takeuchi K, Takeda T (1992) Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 40:1235–1237

    Article  Google Scholar 

  • Takayanagi R, Kitazumi K, Takasaki C, Ohnaka K, Aimoto S, Tasaka K, Ohashi M, Nawata H (1991) Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 282:103–106

    Article  PubMed  CAS  Google Scholar 

  • Takiguchi Y, Sogabe K (1996) The selective endothelin ETA receptor antagonist FR139317 inhibits neointimal thickening in the rat. Eur J Pharmacol 309:59–62

    Article  PubMed  CAS  Google Scholar 

  • Tao W, Liou GI, Wu X, Abney TO, Reinach PS (1995) ETB and epidermal growth factor receptor stimulation of wound closure in bovine corneal epithelial cells. Invest Ophthal Vis Sci 36:2614–2622

    PubMed  CAS  Google Scholar 

  • Teerlink JR, Breu V, Sprecher U, Clozel M, Clozel J-P (1994a) Potent vasoconstriction mediated by ETB receptors in canine coronary arteries. Circ Res 74:105–114

    Article  PubMed  CAS  Google Scholar 

  • Teerlink JR, Loffler BM, Hess P, Maire JP, Clozel M, Clozel JP (1994b) Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47–0203 (bosentan). Circulation 90:2510–2518

    Article  PubMed  CAS  Google Scholar 

  • Telemaque S, Emoto N, deWit D, Yanagisawa M (1998) In vivo role of endothelin-converting enzyme-1 as examined by adenovirus-mediated overexpression in rats.J Cardiovasc Pharmacol 31 [Suppl 1]:S548-S550

    Article  PubMed  CAS  Google Scholar 

  • Terashita Z-I, Shibouta Y, Imura Y, Iwasaki K, Nishikawa K (1989) Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF).Life Sci 45 1911–1918

    Article  PubMed  CAS  Google Scholar 

  • Thiemermann C, Lidbury PS, Thomas GR, Vane JR (1988) Endothelin inhibits ex vivo platelet aggregation in the rabbit. Eur J Pharmacol 158:181–182

    Article  PubMed  CAS  Google Scholar 

  • Tomobe Y, Miyauchi T, Saito A, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. Eur J Pharmacol 152:373–374

    Article  PubMed  CAS  Google Scholar 

  • Tomobe Y, Ishikawa T, Yanagisawa M, Kimura S, Masaki T, Goto K (1991) Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther 257:555–561

    PubMed  CAS  Google Scholar 

  • Tønnessen T, Naess PA, Kirkebøen KA, Ilebekk A, Christensen G (1994) The authors respond. Cardiovasc Res 28:722

    Article  Google Scholar 

  • Topouzis S, Huggins JP, Pelton JT, Miller RC (1991) Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aorta. Br J Pharmacol 102:545–549

    Article  PubMed  CAS  Google Scholar 

  • Toth M, Solti F, Merkely B, Kekesi V, Szokodi I, Horkay F, Juhasz-Nagy A (1998) Bradycardia increases the arrhythmogenic effect of endothelin. J Cardiovasc Pharmacol 31 [Suppl 1]:S431-S433

    Article  PubMed  CAS  Google Scholar 

  • Totsune K, Sone M, Takahashi K, Ohneda M, Itoi K, Murakami O, Saito T, Mouri T, Yoshinaga K (1991) Immunoreactive endothelin in urine of patients with and without diabetes mellitus. J Cardiovasc Pharmacol 17 [Suppl 7]:S423-S424

    Article  PubMed  CAS  Google Scholar 

  • Trachtenberg JD, Sun S, Choi ET, Callow AD, Ryan US (1993) Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol 22 [Suppl 8]:S355–359

    Article  PubMed  CAS  Google Scholar 

  • Tsujino M, Hirata Y, Eguchi S (1995) Nonselective ETA/ETB receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty. Life Sci 56:PL449-PL454

    Article  PubMed  CAS  Google Scholar 

  • Tsunoda K, Abe K, Yoshinaga K, Furuhashi N, Kimura H, Tsujei M, Yajima A (1992) Maternal and umbilical venous levels of endothelin in women with pre-eclampsia. J Hum Hypertension 6:61–64

    CAS  Google Scholar 

  • Van Den Busse M, Itoh S (1993) Central effects of endothelin on baroreflex of spontaneously hypertensive rats. J Hypertension 11:379–387

    Article  Google Scholar 

  • Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C, Lazdunski M (1988) Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 157:977–985

    Article  PubMed  Google Scholar 

  • Vanhoutte PM, Auch-Schwelk W, Boulanger C, Janssen PA, Katusic ZS, Komori K, Miller VM, Schini VB, Vidal M (1989) Does endothelin-1 mediate endothelium-dependent contractions during anoxia? J Cardiovasc Pharmacol 13 [Suppl 5]: S124-S128

    Article  PubMed  CAS  Google Scholar 

  • Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ (1998) Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B blockade. Circulation 97:752–756

    Article  PubMed  CAS  Google Scholar 

  • Vigne P, Lazdunski M, Frelin C (1989) Inotropic effect of endothelin-1 on rat atria involves hydrolysis of phosphatidylinositol. FEBS Lett 249:143–146

    Article  PubMed  CAS  Google Scholar 

  • Viswanathan M, De Oliveira AM, Johren O, Saavedra JM (1997) Increased endothelin ET(A) receptor expression in rat carotid arteries after balloon injury. Peptides 18:247–255

    Article  PubMed  CAS  Google Scholar 

  • Wada K,Tabuchi H, Ohba R (1990) Purification of an endothelin receptor from human placenta. Biochem Biophys Res Commun 167:251–257

    Article  PubMed  CAS  Google Scholar 

  • Walder CE, Thomas GR, Thiemermann C, Vane JR (1989) The hemodynamic effects of endothelin-1 in the pithed rat. J Cardiovasc Pharmacol 13 [Suppl 5]:S93-S97

    Article  PubMed  CAS  Google Scholar 

  • Wang QD, Hemsen A, Li XS, Lundberg JM, Uriuda Y, Pernow J (1995) Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc Res 29:44–49

    PubMed  Google Scholar 

  • Wang X, Douglas SA, Feuerstein GZ, Óhlstein EH (1995) Temporal expression of ECE-1, ET-1, ET-3, ETA and ETB receptor mRNAs after balloon angioplasty in the rat. J Cardiovasc Pharmacol 26 [Suppl 3]:S22-S25

    PubMed  CAS  Google Scholar 

  • Wang Y, Simonson MS, Pousségur J, Dunn MJ (1992) Endothelin rapidly stimulates mitogen-activated protein kinase in rat mesangial cells. Biochem J 287:589–594

    PubMed  CAS  Google Scholar 

  • Wang Y, Pousségur J, Dunn MJ (1993) Endothelin stimulates mitogen-activated protein kinase p42 activity through the phosphorylation of the kinase in rat mesangial cells. J Cardiovasc Pharmacol 22 [Suppl 8]:S164-S167

    Article  PubMed  CAS  Google Scholar 

  • Warner TD, De Nucci G, Vane JR (1989a) Rat endothelin is a vasoactive in the isolated perfused mesentery of the rat. Eur J Pharmacol 159:325–326

    Article  PubMed  CAS  Google Scholar 

  • Warner TD, Mitchell JA, De Nucci G, Vane JR (1989b) Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13 [Suppl 5]:S85-S88

    Article  PubMed  CAS  Google Scholar 

  • Warner TD, Allcock GH, Mickley EJ, Corder R, Vane JR (1993a) Comparative studies with endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J Cardiovasc Pharmacol 22 [Suppl 8]:S117-S120

    Article  PubMed  CAS  Google Scholar 

  • Warner TD, Battistini B, Allcock GH, Vane JR (1993b) Endothelin ETA and ETB receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat. Eur J Pharmacol 250:447–453

    Article  PubMed  CAS  Google Scholar 

  • Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A (1990) Endothelin in myocardial infarction. Nature 344:114

    Article  PubMed  CAS  Google Scholar 

  • Watschinger B, Sayegh MH, Hancock WW, Russell ME (1995) Upregulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol 146:1065–1072

    PubMed  CAS  Google Scholar 

  • Webb DJ (1995) Endogenous endothelin generation maintains vascular tone in humans. J Hum Hypertens 9:459–463

    PubMed  CAS  Google Scholar 

  • Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, Molloy CJ (1994) Endothelin-1 and angiotensin II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 8:148–158

    Article  PubMed  CAS  Google Scholar 

  • Weiser E, Wollberg Z, Kochva E, Lee S (1984) Cardiotoxic effects of the venom of the burrowing asp, Atractaspis engaddensis (Atractasididae, Ophidia). Toxicon 22:767–774

    Article  PubMed  CAS  Google Scholar 

  • Weissberg PL, Witchell C, Davenport AP, Hesketh TR, Metcalfe JC (1990) The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85:257–262

    Article  PubMed  CAS  Google Scholar 

  • Wellings RP, Corder R, Warner TD, Cristol J-P, Thiemermann C, Vane JR (1994) Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 111:515–520

    Article  PubMed  CAS  Google Scholar 

  • White DG, Cannon TR, Garratt H, Mundin JW, Sumner MJ, Watts IS (1992) Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. J Cardiovasc Pharmacol 22 [Suppl 8]:S144-S148

    Google Scholar 

  • Whittle BJR, Lopez-Belmonte J, Rees DD (1989) Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 98:646–652

    Article  PubMed  CAS  Google Scholar 

  • Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC (1994) Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25:2450–2456

    Article  PubMed  CAS  Google Scholar 

  • Willette RN, Sauermelch CF, Storer BL, Guiney S, Luengo JI, Xiang J-N, Elliott JD, Ohlstein EH (1998) Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors. J Cardiovasc Pharmacol 31 [Suppl 1]:S149-S157

    Article  PubMed  CAS  Google Scholar 

  • Wollberg Z, Shabo-Shina R, Intrator N, Bdolah A, Kochva E, Shavit G, Oron Y, Vidne BA, Gitter S (1988) A novel cardiotoxic polypeptide from the venom of atractaspis engaddensis (burrowing asp): cardiac effects in mice and isolated rat and human heart preparations. Toxicon 26:525–534

    Article  PubMed  CAS  Google Scholar 

  • Wong J, Vanderford PA, Winters JW, Chang R, Soifer SJ, Fineman JR (1993) Endothelin-1 does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb. J Cardiovasc Pharmacol 22 [Suppl 8]:S262-S266

    Article  PubMed  CAS  Google Scholar 

  • Wren A, Hiley CR, Fan T-P (1993) Endothelin-3-mediated proliferation in wounded human umbilical vein endothelial cells. Biochem Biophys Res Commun 196:369–375

    Article  PubMed  CAS  Google Scholar 

  • Wright CE, Fozard JR (1988) Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 155:201–203

    Article  PubMed  CAS  Google Scholar 

  • Wright CE, Fozard JR (1990) Differences in regional vascular sensitivity to endothelin-1 between spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 100:107–113

    Article  PubMed  CAS  Google Scholar 

  • Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ (1997) Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 328:733–737

    PubMed  CAS  Google Scholar 

  • Yamauchi T, Ohnaka K, Takakyanagi R (1990) Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 267:16–18

    Article  PubMed  CAS  Google Scholar 

  • Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    Article  PubMed  CAS  Google Scholar 

  • Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T (1990) Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 119:801–806

    Article  PubMed  CAS  Google Scholar 

  • Yorikane R, Koike H (1990) The arrhythmogenic action of endothelin in rats. Jpn J Pharmacol 53:259–263

    Article  PubMed  CAS  Google Scholar 

  • Yorikane R, Sakai S, Miyauchi T, Sakurai T, Sugishita Y, Goto K (1993) Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload.FEBS Lett 332:31–34

    Article  PubMed  CAS  Google Scholar 

  • Yue T-L, Wang X, Sung C-P, Olson B, McKenna PJ, Gu J-L, Feuerstein GZ (1994) Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75:1–7

    Article  PubMed  CAS  Google Scholar 

  • Zamora MA, Dempsey EC, Walchak SJ, Stelzner TJ (1993) BQ-123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol 9:429–433

    CAS  Google Scholar 

  • Zamora MR, O’Brien RF, Rutherford RB, Weil JV (1990) Werum endothelin-1concentrations and cold provocation in primary Reynaud’s phenomenon. Lancet 336:1144–1147

    Article  PubMed  CAS  Google Scholar 

  • Zeiher AM, Goebel H, Schachinger V, Ihling C (1995) Tissue endothelin-1 immunore-activity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91:941–947

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman RS, Martinez AJ, Maymind M, Barbee RW (1992) Effect of endothelin on plasma volume and albumin escape. Circ Res 70:1027–1034

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman RS, Maymind M, Barbee RW (1994) Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 23:205–210

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Douglas, S.A., Ohlstein, E.H. (2001). Vascular and Cardiac Effects of Endothelin. In: Warner, T.D. (eds) Endothelin and Its Inhibitors. Handbook of Experimental Pharmacology, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56899-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56899-2_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63237-2

  • Online ISBN: 978-3-642-56899-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics